High-Risk Clinic for Melanoma Surveillance Is Scalable
TUESDAY, March 23, 2021 -- A structured surveillance program for high-risk melanoma patients can be scaled and successfully replicated even in a primary care skin cancer clinic, according to a study published online March 17 in JAMA...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Melanoma | Pharmaceuticals | Primary Care | Skin | Skin Cancer | Study